NCT01458899View on ClinicalTrials.gov

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Healthy Subjects
Interventions
DRUG

TC-5214

Oral tablets, single 4mg dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY